Cochlear - smart research and commercialisation

Research for What?

English - April 16, 2023 09:03 - 20 minutes - 19.1 MB
Science Technology research impact academia commercialisation start-up Homepage Download Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Bringing art and research together to bring down barriers for people with disabilities

Next Episode: Culturing a woolly mammoth meatball on a Petri dish

In this new episode of Research for What?, I am very privileged to discuss with Dig Howitt, CEO and President of Cochlear Limited, one of Australia’s most celebrated advanced manufacturing success stories.

Cochlear Limited was established in 1983 as a subsidiary of Nucleus, to commercialise the cochlear implant, also known as the bionic ear, an innovative technology developed by Professor Graeme Clark at the University of Melbourne. After more than 40 years of innovative research and sustainable commercialisation, cochlear implants have made significant strides in improving hearing outcomes for individuals with severe-to-profound hearing loss. To date, Cochlear Limited has provided more than 720,000 people with cochlear implants and has a global market share of more than 60%. Their commitment to advancing technology and improving patient outcomes has led to numerous breakthroughs in cochlear implant technology. In this episode, Dig Howitt explains why excellent research and development combined with smart commercialisation, are key elements of Cochlear’s innovation and success. A must listen!!

For direct access to your preferred platform, go to Apple Podcasts, Stitcher, TuneIn, Spotify or Google Podcasts.

Note: this episode was recorded before the last federal election so any reference to the current government actually applies to the former Government.

Hosted on Acast. See acast.com/privacy for more information.